Abiopharma

W. P. Carey Increases Quarterly Dividend to $0.930 per Share

PBF Energy to Participate in Piper Sandler Energy Conference

IAG New Zealand Future-Proofs Claims Operations with Guidewire Cloud Platform

Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock

Infleqtion Appoints Chris O’Brien as Managing Director, Infleqtion Australia

UiPath Expands Strategic Alliance with Deloitte to Launch Agentic ERP

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

📋 MATTHEW RABINOWITZ (Director) plans to sell 200K shares of NATERA, INC. (at $196.61 each, total $39.3M) Filed: Mar 12, 2026 | ID: 002547

Director Turley James S 🟢 acquired 94.5K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003689

📋 ROGERIO VIVALDI COELHO (Director) plans to sell 5K shares of Crinetics Pharmaceuticals, Inc. (at $36.98 each, total $185K) Filed: Mar 12, 2026 | ID: 002543

Director KINDLER JEFFREY B 🟢 acquired 96.3K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003688

📋 STEPHEN MAYO (Director) plans to sell 7K shares of SAREPTA THERAPEUTICS, INC. (at $17.02 each, total $123K) Filed: Mar 12, 2026 | ID: 002538

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

Limoneira Company Announces First Quarter Fiscal Year 2026 Financial Results

PAR Technology Corporation Announces Proposed Offering of $225.0 Million of Convertible Senior Notes